Corpay (NYSE:CPAY) Issues Q4 Earnings Guidance

Corpay (NYSE:CPAY – Get Free Report) issued an update on its fourth quarter earnings guidance on Thursday morning. The company provided EPS guidance of $5.25-5.45 for the period, compared to the consensus EPS estimate of $5.36. The company issued revenue guidance of $1.04-1.07 billion, compared to the consensus revenue estimate of $1.05 billion. Corpay also […]

Leave a Reply

Your email address will not be published.

Previous post Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Pipeline UpdateArcus Biosciences, a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for cancer patients, has announce
Next post 24 more monkeys that escaped from a South Carolina lab are recovered unharmed